Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Context Therapeutics Inc. | 275,000 | reported | 19 Feb 2026 | tx 9+1,210,149 |
| Tempest Therapeutics, Inc. | 110,000 | reported | 26 Feb 2021 | tx 1+110,000 |
1 purchase reported after at least 12 months of silence — most recent on 06 Jun 2025.
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 Feb 2026 | GRANT_AWARD | Context Therapeutics Inc. | 275,000 | 0.00 USD | deriv |
| 06 Jun 2025 | PURCHASE | Context Therapeutics Inc. | 40,010 | 0.64 USD | first after silence |
| 13 Feb 2025 | GRANT_AWARD | Context Therapeutics Inc. | 371,800 | 0.00 USD | deriv |
| 21 Mar 2024 | GRANT_AWARD | Context Therapeutics Inc. | 160,115 | 0.00 USD | deriv |
| 13 Feb 2023 | GRANT_AWARD | Context Therapeutics Inc. | 158,001 | 0.00 USD | deriv |
| 16 Dec 2022 | PURCHASE | Context Therapeutics Inc. | 25,000 | 0.74 USD | |
| 17 Aug 2022 | PURCHASE | Context Therapeutics Inc. | 15,000 | 1.80 USD | |
| 25 Feb 2022 | GRANT_AWARD | Context Therapeutics Inc. | 112,470 | 0.00 USD | deriv |
| 01 Nov 2021 | GRANT_AWARD | Context Therapeutics Inc. | 52,753 | 0.00 USD | deriv |
| 26 Feb 2021 | GRANT_AWARD | Tempest Therapeutics, Inc. | 110,000 | 0.00 USD | deriv |